Citius Oncology CTOR
NASDAQ CTOR
$1.05 +0.02 (+1.94%)
At close: Sep 29, 2026 · 4:00 PM EDT

Citius Oncology (CTOR) Finished Goods (2024 - 2026)

Updated

Citius Oncology (CTOR) recorded Finished Goods of $15.67 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 0.2% from the prior quarter.

Analysis

Citius Oncology (CTOR) Finished Goods (2024 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Citius Oncology reported Finished Goods of $10.58 million, up 72.4% from FY2024.

  • Across earlier fiscal years, Finished Goods came in at $6.13 million in FY2024.
  • Quarterly Finished Goods has ranged from $6.13 million in fiscal Q4 2024 to $15.71 million in fiscal Q2 2026 over the past five years.
  • Per Business Quant, the preceding three fiscal quarters came in at $15.71 million (Q2 2026), $15.69 million (Q1 2026) and $10.58 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Citius Oncology 108.93 Mn 108.93 Mn 1.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15.67 Mn
Mar 31, 2026 15.71 Mn
Dec 31, 2025 15.69 Mn
Sep 30, 2025 10.58 Mn
Sep 30, 2024 6.13 Mn
API Access

Citius Oncology Finished Goods API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=finished-goods&ticker=CTOR&period=max&api_key=YOUR_API_KEY